A Clinical Development Partner for Growing Biotech Companies
Gaea works alongside biotech and pharmaceutical innovators to help bring promising therapies closer to patients. We combine decades of international clinical development experience with a flexible, collaborative approach that adapts to the needs of each programme.
Rather than simply delivering services faster than many, we can become part of your team, providing strategic guidance, operational expertise, and local knowledge across all of Europe and beyond. From early planning through study execution, we focus on building trusted partnerships that support informed decisions, efficient delivery, and long-term success.
Experienced. Focused. Collaborative.
Services
Clinical Project Management
Clinical Project Management
Look moreEnabling Technologies
Enabling Technologies
Look moreSite Feasibility and Selection
Site Feasibility and Selection
Look moreSite Monitoring
Site Monitoring
Look moreClinical data management
Clinical data management
Look morePharmacovigilance
Pharmacovigilance
Look moreQuality Management and Compliance
Quality Management and Compliance
Look morePatient Expense Reimbursement
Patient Expense Reimbursement
Look moreData Protection as a Service
Data Protection as a Service
Look moreIndications
Indications
Look moreNigel Goodman
CEO at Gaea OÜ CRO
I am passionate to bring products for significant diseases with unmet needs through trials in a fast effective way to quickly answer the clinical questions. I don’t believe using the largest CROs is always the cost-effective solution. The largest CROs must run a lot of trials to cover their cost base, though they take even the smallest trial these are small change. By necessity, risk-based monitoring becomes standard, face to face support to site staff is much reduced. Trials at sites are run by people, busy people, also managing patients in routine care.
In addition, my view is companies should all give back to the only world we live in – I choose to give back to sustainability here in Estonia, and education and conservation in Kenya.
Ukrainian patients need clinical research access more even than before and with the incredible engagement of research teams, we can perform clinical trials with fast patient recruitment, and minimum drop-out rates. To help us: on 22nd March 2023 the UA Competent Authority reduced an expert evaluation of a clinical trial application from 47 working days to 30 calendar days and shortened the approval timeline from 5 working days to 5 calendar days, a very significant reduction in time to launch your trial in Ukraine. (MoH order No 190 of 31st of January 2023).
